Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases ...

VRC Medical Services, a women-owned specialty pharmaceutical distribution company supporting clinical research, announced the launch of a dedicated comparator support program designed to help ...

SHANGHAI, Feb 26 (Reuters) - Jiuyuan Genetic Biopharmaceutical has applied for approval to sell its experimental biosimilar version of Novo Nordisk's blockbuster weight-loss drug Wegovy in China, the ...

In the United States, aflibercept-yszy received Food and Drug Administration (FDA) approval in May 2024 as a biosimilar to ...

GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions (688177.SS), a commercial-stage biopharmaceutical company, today announced that dosing has begun in a Phase I clinical study to compare the ...

Biosimilars offer substantial promise for a new era of accessibility and affordability for patients and the broader health care industry, but better understanding of these products from payers and ...

The biosimilar SB4 produced response rates equivalent to those associated with etanercept (ETN; Enbrel, Amgen) in patients with severe rheumatoid arthritis (RA) whose disease was not controlled by ...

The MarketWatch News Department was not involved in the creation of this content. Long Branch, New Jersey--(Newsfile Corp. - February 13, 2026) - VRC Medical Services, a women-owned specialty ...

VRC Medical Services, a women-owned specialty pharmaceutical distribution company supporting clinical research, announced the launch ...